Id2.16.840.1.113883.10.20.22.4.23
ref
ccda-
Gültigkeit ab2014‑06‑09
Statusdraft EntwurfVersions-Label2.1
NameMedicationInformationV2BezeichnungMedication Information (V2)
Beschreibung
en-US A medication should be recorded as a pre-coordinated ingredient + strength + dose form (e.g., “metoprolol 25mg tablet”, “amoxicillin 400mg/5mL suspension”) where possible. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), BPCK (brand pack). The dose (doseQuantity) represents how many of the consumables are to be administered at each administration event. As a result, the dose is always relative to the consumable. Thus, a patient consuming a single "metoprolol 25mg tablet" per administration will have a doseQuantity of "1", whereas a patient consuming "metoprolol" will have a dose of "25 mg".
KontextElternknoten des Template-Element mit Id 2.16.840.1.113883.10.20.22.4.23
KlassifikationCDA Entry Level Template
Offen/GeschlossenOffen (auch andere als die definierten Elemente sind erlaubt)
Benutzt von / Benutzt
Benutzt von 11 Transactions und 82 Templates, Benutzt 0 Templates
Benutzt von als NameVersion
2.16.840.1.113883.3.1937.99.3.4.29Transaktionfinal en-US Progress Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.21Transaktionfinal en-US Care Plan (V2)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.28Transaktionfinal en-US Procedure Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.23Transaktionfinal en-US Continuity of Care Document (CCD) (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.30Transaktionfinal en-US Referral Note (V2)2015‑08‑01
1.3.6.1.4.1.32722.77.77.1.4.6Transaktiondraft nl-NL Verzenden gegevens voor behandeling Longregistratie2012‑12‑27 14:12:19
2.16.840.1.113883.3.1937.99.3.4.27Transaktionfinal en-US Operative Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.31Transaktionfinal en-US Transfer Summary (V2)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.26Transaktionfinal en-US History and Physical (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.25Transaktionfinal en-US Discharge Summary (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.22Transaktionfinal en-US Consultation Note (V3)2015‑08‑01
1.2.276.0.76.3.1.135.8.10.4linkdraft Medical Equipment Section (V2) (2.1)2015‑12‑02 12:50:20
1.2.276.0.76.3.1.135.8.10.99linkcancelled 16: eRezept (duplicate)2018‑11‑02 09:37:45
1.2.276.0.76.10.3117linkdraft Medications Section (entries optional) (V2) (06) (2.1)2016‑09‑06 17:26:48
1.3.6.1.4.1.32722.77.77.1.10.7linkdraft Radiotherapeutische Longregistratie voor aanvang behandeling2013‑02‑20
2.16.840.1.113883.3.51.60.2.4linkpending BC CDA ClinicalDocumentDischargeSummary (V3) (2.1)2019‑03‑19 14:15:51
2.16.840.1.113883.3.51.60.3.34Containmentpending BC CDA Planned Medication Activity (V2) (2.1)2019‑04‑29 08:55:05
2.16.840.1.113883.3.1937.99.61.8.10.3.2linkdraft Plan of Care Section2014‑02‑04 13:11:29
2.16.840.1.113883.3.1937.99.61.8.10.3.4linkdraft Procedures Section (entries required)2014‑02‑04 13:13:02
2.16.840.1.113883.3.1937.99.61.17.10.2linkdraft SHN StructuredBody2015‑05‑09 11:18:02
2.16.840.1.113883.3.1937.99.61.17.10.3linkdraft SHN component2015‑05‑09 11:28:46
2.16.840.1.113883.3.1937.99.61.18.10.6linkdraft Выписной эпикриз2015‑06‑06 14:32:25
2.16.840.1.113883.3.1937.99.61.20.10.9linkdraft Medications Section (entries required) (V2) (2.1)2015‑11‑03 08:58:06
2.16.840.1.113883.3.1937.99.61.21.10.20linkdraft NH MI (fake) Recommendation (2.1)2019‑07‑25 23:56:49
2.16.840.1.113883.3.1937.99.61.26.10.54linkrejected Procedure Activity Procedure (V2) (2.1)2019‑03‑06 15:52:43
2.16.840.1.113883.3.1937.99.61.26.10.55linkdraft Allergy - Intolerance Observation (V2) (2.1)2019‑03‑08 04:36:16
2.16.840.1.113883.3.1937.99.61.26.10.61linkdraft Allergy Concern Act (V3) (2.1)2019‑03‑09 13:34:13
2.16.840.1.113883.3.1937.99.61.26.10.62linkrejected Allergies and Intolerances Section (entries optional) (V3) (2.1)2019‑03‑09 13:37:11
2.16.840.1.113883.3.1937.99.61.26.10.112linkrejected Adverse Events Section (entries optional) (V3) (2.1)2019‑03‑25 06:01:02
2.16.840.1.113883.3.1937.99.61.26.10.114Containmentrejected Medication Activity (V2) (2.1)2019‑03‑31 19:39:09
2.16.840.1.113883.3.1937.99.61.26.10.120Containmentdraft Planned Medication Activity (V2) (2.1)2019‑04‑29 08:53:13
2.16.840.1.113883.3.1937.99.61.26.10.121Containmentdraft Planned Supply (V2) (2.1)2019‑04‑29 09:00:08
2.16.840.1.113883.3.1937.99.61.26.10.122linkdraft Nutrition Recommendation (2.1)2019‑04‑29 09:01:33
2.16.840.1.113883.3.1937.99.61.28.10.3linkdraft CDA de Consulta (1)2017‑04‑22 23:20:01
2.16.840.1.113883.3.1937.99.61.30.10.54linkcancelled Health Concern Act (harmonized) (0.1)2020‑10‑08 10:55:41
2.16.840.1.113883.3.1937.99.61.30.10.58linkdraft _Allergy - Intolerance Observation (harmonization)) (wip)2020‑10‑16 15:17:11
2.16.840.1.113883.3.1937.99.61.30.10.60linkdraft _Immunization (harmonized) (IAT)2021‑07‑06 09:55:32
2.16.840.1.113883.3.1937.99.61.67.10.24linkcancelled XeH Alert Act2021‑04‑20 10:00:04
2.16.840.1.113883.3.1937.99.61.67.10.25linkcancelled XeH Risk Concern Act2021‑04‑20 10:06:56
2.16.840.1.113883.10.20.21.2.3linkdraft Interventions Section (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.2linkdraft Continuity of Care Document (CCD) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.3linkdraft History and Physical (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.4linkdraft Consultation Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.6linkdraft Procedure Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.7linkdraft Operative Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.8linkdraft Discharge Summary (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.9linkdraft Progress Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.13linkdraft Transfer Summary (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.14linkdraft Referral Note (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.15linkdraft Care Plan (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.1linkdraft Medications Section (entries optional) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.1.1linkdraft Medications Section (entries required) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.2linkdraft Immunizations Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.2.1linkdraft Immunizations Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.6linkdraft Allergies and Intolerances Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.6.1linkdraft Allergies and Intolerances Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.7linkdraft Procedures Section (entries optional)2012‑01‑12
2.16.840.1.113883.10.20.22.2.7linkdraft Procedures Section (entries optional) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.7linkpending Procedures Section (entries optional) (V2) (2.1)2019‑03‑16 21:12:43
2.16.840.1.113883.10.20.22.2.7.1linkdraft Procedures Section (entries required) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.10linkdraft Plan of Treatment Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.10linkdraft Plan of Treatment Section (V2) (2.1)2019‑03‑16 08:54:08
2.16.840.1.113883.10.20.22.2.11linkdraft Discharge Medications Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.11.1linkdraft Discharge Medications Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.23linkdraft Medical Equipment Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.25linkdraft Anesthesia Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.38linkdraft Medications Administered Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.44linkdraft Admission Medications Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.58linkdraft Health Concerns Section (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.78Containmentdraft BC CDA Medication Activity (V2) (2.1)2019‑03‑15 14:29:33
2.16.840.1.113883.10.20.22.2.101linkdraft BC CDA Referral Note (V2) (2.1)2019‑04‑06 02:03:17
2.16.840.1.113883.10.20.22.4.7linkdraft Allergy - Intolerance Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.9linkdraft Reaction Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.12linkdraft Procedure Activity Act (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.13linkdraft Procedure Activity Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.14linkdraft Procedure Activity Procedure (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.16Containmentdraft Medication Activity (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.17Containmentdraft Medication Supply Order (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.18Containmentdraft Medication Dispense (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.30linkdraft Allergy Concern Act (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.35linkcancelled Discharge Medication (V3) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.35linkdraft Discharge Medication (V3) (2.1)2016‑03‑01
2.16.840.1.113883.10.20.22.4.36linkdraft Admission Medication (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.42Containmentdraft Planned Medication Activity (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.43Containmentdraft Planned Supply (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.52linkdraft Immunization Activity (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.130linkdraft Nutrition Recommendation (2.1)2015‑08‑13
2.16.840.1.113883.10.20.22.4.131linkdraft Intervention Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.132linkdraft Health Concern Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.135linkdraft Medical Equipment Organizer (2.1)2015‑08‑13
2.16.840.1.113883.10.20.22.4.136linkdraft Risk Concern Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.146linkdraft Planned Intervention Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.24.3.90linkdraft Substance or Device Allergy - Intolerance Observation (V2) (2.1)2014‑06‑09
BeziehungSpezialisierung: Template 2.16.840.1.113883.10.12.312 CDA ManufacturedProduct (2005‑09‑07)
ref
ad1bbr-

Version: Template 2.16.840.1.113883.10.20.22.4.23 Medication Information (2013‑01‑31)
ref
ccda-
ItemDTKardKonfBeschreibungLabel
cda:manufacturedProduct
MedidotsonV2
@classCode
cs1 … 1FMANUCONFdots7408
 en-US SHALL contain exactly one [1..1] @classCode="MANU" (CodeSystem: RoleClass urn:oid:2.16.840.1.113883.5.110 STATIC) (CONF:1098-7408).
cda:templateId
II1 … 1Men-US C-CDA R1.1 templateId root without an extensionCONFdots2936
@root
uid1 … 1F2.16.840.1.113883.10.20.22.4.23
cda:templateId
II1 … 1Men-US SHALL contain exactly one [1..1] templateId (CONF:1098-7409) such that itCONFdots7409
@root
uid1 … 1F2.16.840.1.113883.10.20.22.4.23CONFdots0506
 en-US SHALL contain exactly one [1..1] @root="2.16.840.1.113883.10.20.22.4.23" (CONF:1098-10506).
@extension
st1 … 1F2014-06-09CONFdots2579
 en-US SHALL contain exactly one [1..1] @extension="2014-06-09" (CONF:1098-32579).
cda:id
II0 … *en-US MAY contain zero or more [0..*] id (CONF:1098-7410).CONFdots7410
cda:manufacturedMaterial
1 … 1Men-US SHALL contain exactly one [1..1] manufacturedMaterial (CONF:1098-7411).CONFdots7411
cda:code
1 … 1en-US This manufacturedMaterial SHALL contain exactly one [1..1] code, which SHALL be selected from ValueSet Medication Clinical Drug urn:oid:2.16.840.1.113762.1.4.1010.4 DYNAMIC (CONF:1098-7412).CONFdots7412
 CONF
Der Wert von @code muss gewählt werden aus dem Value Set 2.16.840.1.113762.1.4.1010.4 Medication Clinical Drug (DYNAMIC)
cda:translation
 (preferred)0 … *en-US This code MAY contain zero or more [0..*] translation, which MAY be selected from ValueSet Clinical Substance urn:oid:2.16.840.1.113762.1.4.1010.2 DYNAMIC (CONF:1098-31884).CONFdots1884
 CONF
Der Wert von @code kommt vorzugsweise aus dem Value Set 2.16.840.1.113762.1.4.1010.2 Clinical Substance (DYNAMIC)
cda:manufacturerOrganization
0 … 1en-US MAY contain zero or one [0..1] manufacturerOrganization (CONF:1098-7416).CONFdots7416